Skip to content
ALGS Aligos Therapeutics, Inc. Common Stock
$6.62 -2.22% -0.15
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ALGS stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 41.0M
Enterprise value -8909259
Trailing PE -2.6979592381691
Forward PE -1.6822182
PEG Ratio 0.01884522687507
Enterprise to EBITDA 0.094
Enterprise to revenue -1.894
Price to book MRQ 1.3101032
Price to sales TTM 8.851592

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 4.7M
EBITDA -94589000
Diluted EPS TTM -10.88
Total Cash (MRQ) 54.9M
Current ratio (MRQ) 2.557
Operating Cash Flow (TTM) -84722000

ALGS trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent ALGS News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.